University of Texas Southwestern Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).

837 total trials 162 currently recruiting 503 completed early-phase tilt top decile by trial count

University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.

University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.

Top-decile sponsor footprint

University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

837 total, page 13 of 17

TERMINATED NA

Dual Transcranial Direct Current Stimulation (dTDCS)-Enhanced Therapy After Hemorrhagic Strokes and VEGF

NCT03857243

COMPLETED NA

Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis

NCT02029040

COMPLETED

The Glucose Transporter Type I Deficiency (G1D) Registry

NCT02013583

COMPLETED Phase 1

CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer

NCT01984502

COMPLETED Phase 2

Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial

NCT03638908

COMPLETED Phase 2

High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer

NCT01896271

COMPLETED NA

The Effects of Ankle Foot Orthoses (AFOs) on Mobility in Persons With Multiple Sclerosis (MS)

NCT01947582

COMPLETED Phase 3

Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders

NCT01979133

COMPLETED Phase 1

DHA For The Treatment of Pediatric Concussion Related to Sports Injury

NCT01903525

TERMINATED NA

Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis

NCT01922895

COMPLETED Phase 2

Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)

NCT01818986

COMPLETED NA

Fractional CO2 Laser System (Fraxel Repair Laser) Intended for Treatment of Perioral Rhytides/Wrinkles

NCT03715049

COMPLETED Phase 2

The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension

NCT01996449

COMPLETED

Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism

NCT02064543

COMPLETED Phase 4

Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia

NCT01904864

COMPLETED NA

The Use of Apneic Oxygenation During Prolonged Intubation in Pediatric Patients: a Randomized Clinical Trial

NCT01886807

TERMINATED Phase 2

A Health Intervention to Prevent Depression Hepatitis C Patients

NCT01890083

COMPLETED Phase 2

A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

NCT01838317

COMPLETED Phase 1

DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

NCT00397579

TERMINATED Phase 1

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

NCT02189889

COMPLETED NA

Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies

NCT01710215

TERMINATED Phase 2

Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C

NCT01821625

COMPLETED Phase 1

Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC

NCT01757288

COMPLETED NA

Surgical Success After Laparoscopic vs Abdominal Hysterectomy

NCT01793584

COMPLETED NA

Pain Relief Effects on Length of Labor

NCT01750099

COMPLETED Phase 4

Lurasidone Effects on Tissue Glutamate in Schizophrenia

NCT02199743

COMPLETED Phase 1

Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study

NCT01768637

COMPLETED

Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension

NCT01862497

COMPLETED

Gauging Of Light Dependent Experiences Through Neuroimaging (GOLDEN)

NCT01761032

TERMINATED Phase 4

A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans

NCT01743937

COMPLETED Phase 4

Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor

NCT01778985

COMPLETED Phase 2

Vilazodone for Corticosteroid-Induced Memory Impairment

NCT01828515

TERMINATED NA

Effect of Lower Extremity Ankle Foot Orthoses in Parkinson's Disease

NCT01798927

COMPLETED

Parkinson's Disease Biomarker Program

NCT01767818

COMPLETED

The Utility of Telemedicine in the Management of Migraine

NCT01706003

COMPLETED Phase 3

Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer

NCT01459497

COMPLETED Phase 2

Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension

NCT01682837

COMPLETED NA

Pet Ownership and Glucose Control in Type 1 Diabetes

NCT01733524

COMPLETED Phase 4

Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension

NCT02653560

TERMINATED NA

Effectiveness of Ankle Foot Orthoses on Gait in Multiple Sclerosis

NCT01796860

COMPLETED Phase 1

A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma

NCT01634685

COMPLETED NA

Exercise Training Sequence for Subacromial Impingement Syndrome

NCT02478567

COMPLETED NA

HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer

NCT02165605

COMPLETED

Pharmacologic MRI in Cocaine Addiction

NCT01652378

TERMINATED NA

Evaluation of Early Standardized Task-Specific Training (ESTT)

NCT01774110

COMPLETED NA

The Effect of Long Duration Exercise on the Diastolic Function of the Heart

NCT02039154

COMPLETED Phase 2

Treatment for Calcium Phosphate Kidney Stone Disease

NCT01754779

COMPLETED Phase 4

Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome

NCT01654276

COMPLETED

Hippocampal Neurogenesis in Human Subjects

NCT02028273

COMPLETED NA

Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea

NCT01799174

← Previous Page 13 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 106
Phase 2 122
Phase 3 28
Phase 4 98

What is open in the University of Texas Southwestern Medical Center pipeline

162 recruiting of 837 indexed (19% open); 503 completed (60%).

Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).

Top condition: Hypertension (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Texas Southwestern Medical Center: open-pipeline peers nationwide

Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of Texas Southwestern Medical CenterUniversity of UtahUniversity of ChicagoIndiana UniversityDana-Farber Cancer InstituteCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalAnn & Robert H Lurie Children's Hospital of ChicagoVanderbilt University Medical Center
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 837 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of Texas Southwestern Medical Center page

837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.

  • 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.